MUSTANG BIO, INC. — Investor Relations & Filings
Filings indexed
399
across all filing types
Latest filing
2026-05-05
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
MBIO
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cell and gene therapies. The company's primary focus is on translating medical breakthroughs into potential cures for difficult-to-treat cancers and rare genetic diseases. Its pipeline is centered on Chimeric Antigen Receptor (CAR) T-cell therapies, a form of immunotherapy. Mustang Bio's strategy involves in-licensing promising technologies from academic institutions and advancing them through clinical trials, supported by its in-house manufacturing capabilities to ensure the production and delivery of these advanced treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - MUSTANG BIO, INC. (0001680048) (Filer) | 2026-05-05 | English | |
| 8-K - MUSTANG BIO, INC. (0001680048) (Filer) | 2026-04-17 | English | |
| Major Shareholding Notification 2026 | 2026-01-05 | English | |
| Director's Dealing 2026 | 2026-01-05 | English | |
| OWNERSHIP DOCUMENT | 2025-12-30 | English | |
| OWNERSHIP DOCUMENT | 2025-12-30 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 41519352 | 10-Q - MUSTANG BIO, INC. (0001680048) (Filer) | 2026-05-05 | English | ||
| 34661932 | 8-K - MUSTANG BIO, INC. (0001680048) (Filer) | 2026-04-17 | English | ||
| 12973079 | Major Shareholding Notification 2026 | 2026-01-05 | English | ||
| 12973078 | Director's Dealing 2026 | 2026-01-05 | English | ||
|
2025
11 filings
| |||||
| 12973080 | OWNERSHIP DOCUMENT | 2025-12-30 | English | ||
| 12973081 | OWNERSHIP DOCUMENT | 2025-12-30 | English | ||
| 12973082 | OWNERSHIP DOCUMENT | 2025-12-30 | English | ||
| 12973084 | 8-K | 2025-12-23 | English | ||
| 12973083 | DEF 14A | 2025-12-03 | English | ||
| 12973085 | 10-Q | 2025-11-07 | English | ||
| 12973086 | Major Shareholding Notification 2025 | 2025-10-01 | English | ||
| 12973089 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 12973087 | 424B5 | 2025-09-05 | English | ||
| 12973088 | Major Shareholding Notification 2025 | 2025-08-12 | English | ||
| 12973090 | 10-Q | 2025-08-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
MUSTANG BIO, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35167/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35167 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35167 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35167 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35167}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MUSTANG BIO, INC. (id: 35167)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.